-DFUR 600 mg/body p.o. everyday

2 trials

Sponsors

Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine

Conditions

Advanced or recurrent gastric cancerAdvanced or recurrent gastric cancer previously treated with S-1

Phase 2

Phase II study of a Combination of Paclitaxel and 5'-DFUR in Patients with S-1 Failure Unresectable or Recurrent Gastric Cancer

RecruitingJPRN-UMIN000008632

Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of MedicineAdvanced or recurrent gastric cancer previously treated with S-1

Start: 2007-10-01Target: 35Updated: 2026-06-29

Multi-center, phase II study for combination therapy with weekly pacritaxel and 5'-DFUR in patients with unresectable or recurrent gastric cancer

Active, not recruitingJPRN-UMIN000008631

Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of MedicineAdvanced or recurrent gastric cancer

Start: 2004-03-01Target: 45Updated: 2026-06-29